Integrative Potential and Clinical Insight From a functional medicine perspective, GLP-1, GLP-2, and VIP peptides could become adjunctive supports in MCAS and related conditions such as IBS, POTS, EhlersDanlos syndrome, chronic fatigue, and long COVID, where mast-celldriven neuroinflammation plays a central role
For people with type 2 diabetes, the SURPASS trial series demonstrated exceptional glycemic control alongside weight loss, which is why the compound received its first approval for diabetes before the obesity indication followed
See our medical disclaimer for full details
(Cham: Springer International Publishing), 253264
Enhanced Physical Recovery Supports anabolic hormone release during sleep (GH, IGF-1) May speed up recovery from intense training or injury 4